PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2021-01-11

Date Title Company
11-Jan-2021 Aviceda Therapeutics Announces Formation of Executive Team Businesswire
11-Jan-2021 Personal Genome Diagnostics and Almac Diagnostic Services Enter Strategic Collaboration to Enhance Patient Care in Oncology Businesswire
11-Jan-2021 PolarityTE Announces Formation of Strategic Review Committee Businesswire
11-Jan-2021 Receptor Life Sciences Receives FDA Guidance for Development of RLS 103, Designed for the Treatment of Acute Panic Attack Businesswire
11-Jan-2021 Zymeworks Highlights 2020 Achievements and Announces Corporate Priorities Businesswire
11-Jan-2021 Dwayne Johnson, Dany Garcia, Dave Rienzi & John Shulman Announce Forthcoming Launch of ZOA™ Energy Drink Businesswire
11-Jan-2021 Magenta Therapeutics Highlights Recent Progress and Expected Timing of 2021 Milestones, Including Four Ongoing and Planned Clinical Trials Businesswire
11-Jan-2021 Charles River Laboratories to Present at J.P. Morgan Healthcare Conference Businesswire
11-Jan-2021 Istari Oncology Announces FDA Grants Orphan Drug Designation for PVSRIPO for the Treatment of Advanced Melanoma Businesswire
11-Jan-2021 Artificial intelligence in Healthcare Report 2020 - Global Market Forecast to 2027 - ResearchAndMarkets.com Businesswire
11-Jan-2021 Axcella Announces IND Clearance for AXA1665, Program Updates and 2021 Milestones Businesswire
11-Jan-2021 Global Microbiome Therapeutics (Fungi, Bacteria, Bacteriophage, Viruses, and Protozoa) Markets, 2019-2020 & 2030: Focus on Target Therapies, Region (10 Countries), and Competitive Landscape - ResearchAndMarkets.com Businesswire
11-Jan-2021 Medable Sets Stage for Broad Decentralized Clinical Trial Adoption in 2021 Businesswire
11-Jan-2021 Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines Businesswire
11-Jan-2021 Exicure Granted Two Fast Track Designations for Cavrotolimod (AST-008) from the U.S. Food and Drug Administration Businesswire
11-Jan-2021 Shape Therapeutics to Highlight RNA Editing Technology Platform Advancements in Parkinson’s Disease and the Identification of Novel CNS-targeting AAV Variants at the J.P. Morgan 39th Annual Healthcare Conference Businesswire
11-Jan-2021 Louis Pascarella Appointed Chief Executive Officer of Innocoll Businesswire
11-Jan-2021 Strand Therapeutics and BeiGene Enter into Agreement to Develop Solid Tumor Immuno-Oncology Therapeutics Based on Strand’s Next-Generation, Multi-Functional mRNA Technology Businesswire
11-Jan-2021 Blade Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference Businesswire
11-Jan-2021 Takeda to Present at The 39th Annual J.P. Morgan Healthcare Conference Businesswire